A patient with gout has been shown in a broad range of studies to be at higher risk of coronary disease , and should have an evaluation appropriate to coronary risk (for example, lab testing for cholesterol and triglyceride level).3 It is important that damage to bone from gout be diagnosed, since documented damage is a clear indication for long-term therapy (see below)
GLP-1 medications are not approved specifically for PMOS
There is a consensus that various types of cancer may arise from interactions between free radicals and DNA, leading to genotoxic damage
For higher-risk patients, the guidance suggests targeted mitigation strategies
GLP-1 medications improve sugar processing through several mechanisms: Enhances insulin action : These medications increase cellular responsiveness to insulin, facilitating better sugar movement from bloodstream to cells 5
At Blooming Wellness & Weightloss, we offer Vitamin B12 injections for eligible individuals, following a thorough medical evaluation